Deutsche Bank
CTKB icon

Deutsche Bank’s Cytek Biosciences CTKB Stock Holding History

Deutsche Bank’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$496K Buy
111,932
+7,495
+7% +$32K ﹤0.01% 2779
2026
Q1 		$456K Buy
104,437
+11,298
+12% +$53.3K ﹤0.01% 2617
2025
Q4 		$470K Buy
93,139
+4,119
+5% +$19.1K ﹤0.01% 2606
2025
Q3 		$309K Buy
89,020
+11,972
+16% +$44.9K ﹤0.01% 2830
2025
Q2 		$262K Sell
77,048
-16,906
-18% -$56.3K ﹤0.01% 2816
2025
Q1 		$377K Sell
93,954
-9,228
-9% -$47.8K ﹤0.01% 2632
2024
Q4 		$670K Buy
103,182
+36,542
+55% +$218K ﹤0.01% 2468
2024
Q3 		$369K Buy
66,640
+9,725
+17% +$55.1K ﹤0.01% 2625
2024
Q2 		$318K Sell
56,915
-10,241
-15% -$61.5K ﹤0.01% 2568
2024
Q1 		$451K Buy
67,156
+1,552
+2% +$12.3K ﹤0.01% 2408
2023
Q4 		$598K Sell
65,604
-1,258
-2% -$7.92K ﹤0.01% 2289
2023
Q3 		$369K Buy
66,862
+15,811
+31% +$127K ﹤0.01% 2366
2023
Q2 		$436K Sell
51,051
-24,043
-32% -$216K ﹤0.01% 2435
2023
Q1 		$690K Buy
75,094
+18,637
+33% +$200K ﹤0.01% 2309
2022
Q4 		$576K Buy
56,457
+4,790
+9% +$64.4K ﹤0.01% 2364
2022
Q3 		$761K Sell
51,667
-5,725
-10% -$74.4K ﹤0.01% 2141
2022
Q2 		$616K Buy
57,392
+2,808
+5% +$27.9K ﹤0.01% 2471
2022
Q1 		$588K Buy
54,584
+44,165
+424% +$596K ﹤0.01% 2650
2021
Q4 		$170K Buy
10,419
+543
+5% +$11.4K ﹤0.01% 3456
2021
Q3 		$212K Buy
+9,876
New +$232K ﹤0.01% 3538

Other funds holding CTKB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Deutsche Bank's CTKB Position: Q2 2026 in Review

Deutsche Bank increased its Cytek Biosciences (CTKB) stake by 7.2% in Q2 2026, buying an estimated $32K and bringing the position to 111,932 shares worth $496K. The position accounts for ﹤0.01% of the portfolio, ranked #2779.

Deutsche Bank first reported a position in CTKB in Q3 2021 and has held it in 20 quarters since. The position peaked at $761K in Q3 2022. 154 funds tracked by Wall St. Rank hold CTKB as of Q2 2026.

  • Deutsche Bank held 111,932 shares of Cytek Biosciences worth $496K as of Q2 2026.
  • Deutsche Bank bought 7,495 Cytek Biosciences shares in Q2 2026, an estimated $32K.
  • Cytek Biosciences made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2779 holding.
  • Deutsche Bank first reported a position in Cytek Biosciences in Q3 2021 and has held it in 20 quarters since.
  • Deutsche Bank's Cytek Biosciences position peaked at $761K in Q3 2022.
  • 154 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.